(Q48401292)

11 February 2018

title

Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology. (English)

1 reference

11 February 2018

0 references

0 references

D Muyllaert

1

1 reference

11 February 2018

D Terwel

2

1 reference

11 February 2018

P Borghgraef

3

1 reference

11 February 2018

H Devijver

4

1 reference

11 February 2018

I Dewachter

5

1 reference

11 February 2018

F Van Leuven

6

1 reference

11 February 2018

publication date

1 October 2006

1 reference

11 February 2018

published in

Revue neurologique

1 reference

11 February 2018

volume

162

1 reference

11 February 2018

page(s)

903-907

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Aging increased amyloid peptide and caused amyloid plaques in brain of old APP/V717I transgenic mice by a different mechanism than mutant presenilin1

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Secretases as targets for the treatment of Alzheimer's disease: the prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Capacitative calcium entry induces hippocampal long term potentiation in the absence of presenilin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Identification and isolation of a hyperphosphorylated, conformationally changed intermediate of human protein tau expressed in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Microtubule binding and clustering of human Tau-4R and Tau-P301L proteins isolated from yeast deficient in orthologues of glycogen synthase kinase-3beta or cdk5.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Transgenic mouse models for APP processing and Alzheimer's disease: early and late defects.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Single and multiple transgenic mice as models for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

Pathology of cerebrospinal fluid and interstitial fluid of the CNS: significance for Alzheimer disease, prion disorders and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2975098-6

7 January 2021

10.1016/S0035-3787(06)75098-6

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

17028556

1 reference

11 February 2018